Todd Shegog's most recent trade in Cogent Biosciences Inc was a trade of 44,700 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 5, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Cogent Biosciences Inc | Todd E. Shegog | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 44,700 | 44,700 | - | - | Stock Option (Right to Buy) | |
Cogent Biosciences Inc | Todd E. Shegog | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 36,700 | 36,700 | - | - | Stock Option (Right to Buy) | |
Cogent Biosciences Inc | Todd E. Shegog | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 30,700 | 30,700 | - | - | Stock Option (Right to Buy) | |
Cogent Biosciences Inc | Todd E. Shegog | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2021 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
Cogent Biosciences Inc | Todd E. Shegog | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2021 | 37,500 | 37,500 | - | - | Stock Option (Right to Buy) |